Quantcast

Latest NewCardio Inc. Stories

2009-05-14 07:00:00

Platform Technology, QTinno(TM) and Visual3Dx(TM) to be introduced at prestigious conference Information located at booth 468 SANTA CLARA, Calif., May 14 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that the Company will introduce the NewCardio platform, QTinno(TM) and Visual3Dx(TM) at Heart Rhythm 2009, today through May 16, 2009. The Company will be located at booth number 468 at the Boston Convention and...

2009-04-07 07:00:00

Company to Present and Participate in Panel Discussions at DIA Conference in Bethesda, Maryland April 29-May 1, 2009 SANTA CLARA, Calif., April 7 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that senior leadership will present clinical data, discuss applications for its proprietary technology, and participate in panel discussion at the Drug Information Association (DIA) Cardiovascular Safety and QT/Arrhythmia...

2009-03-31 07:00:00

Company to Present Data on the Use of its Proprietary Technology to Provide Accurate, Fully Automated ECG Analysis for Drug Cardiac Safety at 34th Annual ISCE Meeting SANTA CLARA, Calif., March 31 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that senior leadership will present clinical data from two abstracts and discuss applications for its proprietary technology at the 34th Annual International Society for...

2009-03-10 07:00:00

Mr. Hanson Adds Marketing Expertise, Pharmaceutical Industry and Investment Experience to Company's Board of Directors SANTA CLARA, Calif., March 10 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced the election of Michael E. Hanson to the Company's Board of Directors. Mr. Hanson joins the board April 1, 2009. With this election, NewCardio's board now includes seven directors, including five independent...

2009-03-04 07:00:00

Data have also been accepted for publication as an original article by the peer-reviewed Journal of Electrocardiology SANTA CLARA, Calif., March 4 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dr. Ihor Gussak, NewCardio's Vice President and Chief Medical Officer, will present at the American College of Cardiology (ACC) 58th Annual Scientific Session in Orlando on March 29, 2009. Dr. Gussak, on behalf...

2009-01-22 06:00:00

NewCardio to work closely with regulators, academia and pharmaceutical industry in the development of advanced ECG cardiac safety tools SANTA CLARA, Calif., Jan. 22 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced it has become a member of the Cardiac Safety Research Consortium (CSRC). The CSRC (www.cardiac-safety.org) is a broad-based collaboration of medical product safety experts from academia, industry, and...

2009-01-07 07:00:00

Management to Present at 9:45 a.m. on the 13th with Breakout Session to Follow SANTA CLARA, Calif., Jan. 7 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Branislav Vajdic, the Company's Chief Executive Officer, and Vincent Renz, the Company's President, will present at the "OneMedForum 2009" finance conference, to be held January 13-14, 2009, in San Francisco at the Sir Francis Drake Hotel. NewCardio's...

2008-12-11 07:00:00

Current CardioDX CMO and former Executive Director of AstraZeneca to help advance NewCardio's platform technology SANTA CLARA, Calif., Dec. 11 /PRNewswire-FirstCall/ --NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Philip T. Sager, M.D., FACC, FAHA, FHRS, has joined the Company's Scientific Advisory Board. Dr. Sager is currently the Chief Medical Officer of CardioDX, a cardiovascular genomic diagnostics company focused on serving...

2008-12-03 06:00:00

SANTA CLARA, Calif., Dec. 3 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that it has completed a restructure of the going-forward terms of its December 27, 2007 financing. As a result of this agreement, the investors in the transaction have exercised a portion of their existing warrants, adding $2.8 million in cash to NewCardio's balance sheet. This will extend the Company's cash reserves to past the...

2008-08-05 09:01:31

NewCardio, Inc. (OTCBB: NWCI), a cardiac diagnostic and services company, announced today that Ihor Gussak, M.D., Ph.D., FACC, world-recognized expert in electrocardiology and cardiac safety, has joined the Company as its new Chief Medical Officer and Vice President, effective immediately. Dr. Gussak joins NewCardio from Boehringer Ingelheim Pharmaceuticals, where he held a senior executive role for the past year. Previously, Dr. Gussak served 5 years as Vice President, Global Medical...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.